Emerging research reveals how fasting and timed eating may enhance brain cell function and slow neurodegenerative disease progression through autophagy and mitochondrial efficiency. New studies demons...
A recent pilot study highlights the safety of intravenous BPC-157 in humans, reinforcing its potential for treating musculoskeletal injuries and accelerating tissue repair. New research validates the ...
New research suggests time-restricted eating may improve mitochondrial function and reduce protein aggregates in early-stage Huntington’s disease patients. Emerging evidence indicates TRE may offer ...
A 12-week TRE intervention with 6-8h eating windows demonstrates potential benefits for HD patients by improving mitochondrial function and cognitive scores, though adherence challenges remain. Emergi...
Recent breakthroughs in herbal cubosome technology offer promising solutions for arthritis treatment, improving bioavailability and reducing side effects through advanced nanotechnology. Cutting-edge ...
Recent studies reveal urolithin A from pomegranate enhances mitochondrial function, improving exercise tolerance in statin users by 18% over 8 weeks. New research shows pomegranate-derived urolithin A...
The first human pilot study on intravenous BPC-157 demonstrates safety and tolerability, while preclinical data suggests potential in gut health, wound healing, and neuroprotection. The synthetic pept...
New research highlights the role of omega-3s, vitamin D, and personalized diets in managing endocrine therapy side effects, with AI offering tailored solutions. Emerging studies show personalized nutr...
Cubosome technology improves delivery of anti-inflammatory herbal compounds like curcumin and boswellia, offering a promising alternative to conventional arthritis drugs with fewer side effects. Advan...
Recent studies show NLC-encapsulated curcumin and EGCG significantly improve skin retention and SIRT1 expression, offering promising anti-aging benefits. NLC-encapsulated curcumin and EGCG show enhanc...
